A multiparameter test of clot formation and fibrinolysis for in-vitro drug screening
Authors:
- Jadwiga ParaJPJadwiga Para
- Joanna SikoraJSJoanna Sikora
- 1 October 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 18 (7) , 611-618
Abstract
A large spectrum of methods has been used in both routine and scientific studies of the hemostatic system. The particular interest of the investigators has been focused on methods simultaneously evaluating clotting and fibrinolysis processes. The aim of the present study was to develop an optical method for overall evaluation of clot formation and lysis (CL-test) that could be used in drug screening. The CL-test was performed in citrate plasma diluted with Tris-buffered saline. Thrombin was applied for plasma clotting (0.5 IU/ml), while tissue plasminogen activator (60 ng/ml) was used for fibrinolysis activation. Clot formation and lysis were monitored in thermostatic conditions (37°C) as a continuous record of transmittance change. By means of own computer program, kinetic parameters of the processes studied and plasma overall clot formation and fibrinolysis potential, expressed as the area under the clotgeneration and fibrinolysis curves, were calculated. The CL-test was developed and checked by evaluation of the effect, on clot formation and lysis, of various concentrations of acetylsalicylic acid (a drug that affects hemostasis), aprotinin (fibrinolysis activator) and venoruton (fibrinolysis inhibitor). The obtained results confirmed that the test we propose for monitoring clot formation, stabilization and lysis is sensitive and enables precise estimation of the processes studied. In our opinion, it can be a useful tool in drug screening investigations.Keywords
This publication has 26 references indexed in Scilit:
- A new nitrate derivative of piperazine: its influence on platelet activityBlood Coagulation & Fibrinolysis, 2007
- Reduced fibrinolysis and increased fibrin generation can be detected in hypercoagulable patients using the overall hemostatic potential assayJournal of Thrombosis and Haemostasis, 2007
- Aspirin Alters the Cardioprotective Effects of the Factor XIII Val34Leu PolymorphismCirculation, 2003
- Pharmacokinetic and Pharmacodynamic Differences Between Two Low Dosages of Aspirin May Affect Therapeutic OutcomesClinical Pharmacokinetics, 2003
- A Simple and Rapid Laboratory Method for Determination of Haemostasis Potential in PlasmaThrombosis Research, 2001
- Fibrin Clot Formation and Lysis: Basic MechanismsSeminars in Thrombosis and Hemostasis, 2000
- Influence of Fibrin Network Conformation and Fibrin Fiber Diameter on Fibrinolysis SpeedArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Inhibition of Thrombin Generation by Aspirin Is Blunted in HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Effect of fibrin structure on plasmin-mediated dissolution of plasma clotsBlood Coagulation & Fibrinolysis, 1995
- Aspirin as an Antiplatelet DrugNew England Journal of Medicine, 1994